Charles River Laboratories (CRL) - Compare | Sterling
Revenue Flow
Chart: Revenue Flow for Charles River Laboratories. Q2 2026, values in USD. Revenue 47%, Cost of Revenue 30%, Gross Profit 17%, Operating Income 6%, Net Income 0%.
Balance Sheet
Chart: Balance Sheet for Charles River Laboratories. Values in currency. In Q2 2026: Total Assets 7.532, Total Liabilities 4.686, Total Equity 2.84.
Q3 2016-Q2 2026
Cash Flow
Chart: Cash Flow for Charles River Laboratories. Values in currency. In Q2 2026: Operating Cash Flow 0.18, Free Cash Flow 0.149, Capital Expenditures 0.031.
Q3 2016-Q2 2026
Revenue Breakdown
Chart: Revenue Breakdown for Charles River Laboratories. Values in USD billions. In Q2 2026: Revenue 1.004, Gross Profit 0.363, Operating Income 0.12.